Mitsubishi Ufj Asset Management (Uk) Ltd. Merck & Co., Inc. Transaction History

Mitsubishi Ufj Asset Management (Uk) Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$113.24 - $131.95 $1.81 Million - $2.11 Million	16,000 New	16,000 $2.11 Million
Q2 2021 Jul 20, 2021	SELL	$70.31 - $77.77 $1.27 Million - $1.4 Million	-18,000 Closed	0 $0
Q1 2021 Apr 21, 2021	SELL	$68.86 - $81.11 $137,720 - $162,220	-2,000 Reduced 10.0%	18,000 $1.32 Million
Q4 2020 Jan 26, 2021	SELL	$71.77 - $79.65 $2.94 Million - $3.27 Million	-41,000 Reduced 67.21%	20,000 $1.56 Million
Q2 2018 Jul 16, 2018	BUY	$50.83 - $59.72 $3.1 Million - $3.64 Million	61,000 New	61,000 $0
Q4 2017 Jan 19, 2018	SELL	$51.62 - $61.64 $3.05 Million - $3.64 Million	-59,000 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$58.67 - $63.13 $3.46 Million - $3.72 Million	59,000	59,000 $0

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Asset Management (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Mitsubishi Ufj Asset Management (Uk) Ltd. with notifications on news.